SCHEMBL652482

SCHEMBL652482

C#Cc1cncc(N2C[C@H]3CCN(C(=O)OC(C)(C)C)[C@H]3C2)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
GPR119 Q8TDV5 9/20 0.41
RET P07949 1/20 0.41
CHRNB2 P17787 4/20 0.39
CHRNB4 P30926 4/20 0.39
CHRNA3 P32297 4/20 0.39
CHRNA4 P43681 4/20 0.39
USP30 Q70CQ3 1/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
SPR P35270 1/20 0.36
CHRNA1 P02708 2/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRND Q07001 1/20 0.35
CHRNA2 Q15822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653685 0.90 RET (0.46) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL653388 0.87 UCHL1 (0.40) NR1H2NR1H3GPR119RETUSP30
SCHEMBL652009 0.85 GPR119 (0.45) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL650737 0.85 GPR119 (0.43) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL650034 0.85 GPR119 (0.43) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL3583331 0.84 CHRNB4 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA1
SCHEMBL654584 0.84 CHRNB2 (0.47) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL650797 0.84 CHRNB2 (0.47) NR1H2NR1H3GPR119RETCHRNB2
SCHEMBL649506 0.83 RET (0.43) NR1H2NR1H3GPR119RETCHRNB4
SCHEMBL650661 0.83 NR1H2 (0.42) NR1H2NR1H3GPR119RETUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed